(Q47614080)

4 February 2018

title

Induction of a mucosal immune response to the streptococcal M protein by intramuscular administration of a PADRE-ASREAK peptide (English)

1 reference

4 February 2018

author name string

Pamonsinlapatham P

1

1 reference

4 February 2018

Decroix N

2

1 reference

4 February 2018

Mihaila-Amrouche L

3

1 reference

4 February 2018

Bouvet A

4

1 reference

4 February 2018

Bouvet JP

5

1 reference

4 February 2018

publication date

1 May 2004

1 reference

4 February 2018

Scandinavian Journal of Immunology

published in

1 reference

4 February 2018

volume

59

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

page(s)

504-510

1 reference

4 February 2018

Pathogenesis of group A streptococcal infections

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Stimulation of local antibody production: parenteral or mucosal vaccination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Streptococcal M protein: molecular design and biological behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Evaluation of synthetic, M type-specific peptides as antigens in a multivalent group A streptococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Immunogenicity of a 26-valent group A streptococcal vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

A three-tiered view of the role of IgA in mucosal defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Contribution of serum immunoglobulin transudate to the antibody immune status of murine intestinal secretions: influence of different sampling procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Mucosal immunity induced by intramuscular administration of free peptides in-line with PADRE: IgA antibodies to the ELDKWA epitope of HIV gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Induction in mucosa of IgG and IgA antibodies against parenterally administered soluble immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

"PERFEXT": a direct method for quantitative assessment of cytokine production in vivo at the local level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

Public health. Aluminum is put on trial as a vaccine booster

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adju

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

High affinity serum-derived Fab fragments as another source of antibodies in the gut lumen of both neonates and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0300-9475.2004.01421.X

10.1111/J.0300-9475.2004.01421.X

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018